Remove 2014 Remove Competition Remove Networking Remove Pharmaceutical manufacturing
article thumbnail

What factors are driving life sciences FDI in 2022?

Pharmaceutical Technology

Locating a subsidiary in close proximity to such an institution has advantages beyond pipeline talent, as there is the potential to access research and tap into networks for product development and clinical trials. Industry clusters. Locations with access to the sea may also offer a cheaper way of transporting goods.

article thumbnail

Call to arms as UK falls back in medicines manufacturing

pharmaphorum

Drastic steps need to be taken if the UK is to reverse a steep decline in medicines manufacturing in recent years, according to a cross-industry coalition. Since 2010, the UK has fallen from 4th to 98th place in overall trade balance in pharmaceuticals, due to fierce global competition, according to the MMIP.